Table: Immuno Biological Lab -2025/26 parent results
May 13 (Reuters)-
Immuno Biological Laboratories Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.00 959 mln
(+4.4 pct) (+18.1 pct)
Operating 285 mln 207 mln
(+37.7 pct) (+83.9 pct)
Recurring 316 mln 219 mln
(+44.0 pct) (+50.8 pct)
Net 319 mln 249 mln
(+28.2 pct) (+33.4 pct)
EPS 34.27 yen 26.74 yen
Ann Div 6.00 yen NIL 7.50 yen
-Q2 Div NIL NIL NIL
-Q4 Div 6.00 yen NIL 7.50 yen
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T